Edward J Leonard

Title: Edward J Leonard: Innovator in Monocyte Chemotactic Products

Introduction

Edward J Leonard is a notable inventor based in Chevy Chase, MD (US). He holds a total of 12 patents that contribute significantly to the field of medical science, particularly in the treatment of infections and neoplasms.

Latest Patents

Among his latest patents is a human-derived monocyte attracting purified protein product that is useful in treating infections and neoplasms in the human body. This invention includes pure peptide products derived from either the human glioma cell line U-105MG or human peripheral blood mononuclear leukocytes. These products have a molecular mass of about 8,400 daltons and exhibit optimal monocyte chemotactic activity at a concentration of 1 nM. The patent also covers the cloning of full-length cDNA for these peptide products, as well as recombinant methods for producing monocyte chemoattractant products. Furthermore, it outlines methods for treating infections and neoplasms in the human body using these peptides and monocyte chemoattractant products, along with pharmaceutical compositions for the same.

Career Highlights

Edward J Leonard has made significant contributions while working with the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been pivotal in advancing the understanding and treatment of various medical conditions.

Collaborations

Throughout his career, Leonard has collaborated with esteemed colleagues such as Teizo Yoshimura and Ettore Appella. These collaborations have further enriched his research and innovations in the field.

Conclusion

Edward J Leonard's contributions to medical science through his patents and collaborations highlight his role as a significant innovator in the field of monocyte chemotactic products. His work continues to pave the way for advancements in treating infections and neoplasms.